You are viewing: South Korea Biosurgery Market analysis
Part of: Biosurgery Market (Global)

The South Korea Biosurgery Market was valued at $272.2 Million in 2025 and projected to reach to $369.1 Million by 2030, representing a compound annual growth rate of 6.3%. South Korea's biosurgery market is positioned for sustained growth through 2030, driven by an aging population requiring increased surgical interventions and rising healthcare expenditure.

South Korea Biosurgery Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

South Korea Biosurgery Market Trends and Insights

  • South Korea's advanced healthcare infrastructure, high surgical volumes, and strong adoption of minimally invasive techniques are driving demand for biosurgical products.
  • The market in South Korea benefits from increasing geriatric population, rising prevalence of chronic diseases, and significant investment in medical device innovation. South Korea's biosurgery sector is characterized by robust regulatory frameworks and a competitive landscape dominated by both domestic and international players.
  • South Korea's healthcare system prioritizes cutting-edge surgical solutions, supporting market expansion through 2030.
  • The country's emphasis on research and development, coupled with favorable reimbursement policies, positions South Korea as a key growth market within the Asia Pacific region..

Key Market Statistics

  • CAGR (2025-2030) 6.3% CAGR
  • Market Size, 2025 ~USD 272.2 Million
  • Forecast, 2030 ~USD 369.1 Million
  • Country South Korea

South Korea Biosurgery Market Overview

Market Valuation :

South Korea's biosurgery market is valued at USD 272.2 million in 2025, with projected growth to USD 369.1 million by 2030, representing a steady CAGR of 6.3%.

Advanced Healthcare Infrastructure :

South Korea's state-of-the-art medical facilities and high surgical volumes create a robust demand environment for innovative biosurgical products and solutions.

Minimally Invasive Adoption :

Strong adoption of minimally invasive surgical techniques across South Korean hospitals drives increased utilization of biosurgical hemostats, sealants, and adhesion barriers.

Regulatory Support :

South Korea's progressive regulatory framework and rapid approval pathways for medical devices facilitate faster market entry and commercialization of biosurgical innovations.

South Korea Biosurgery Market Dynamics

  • The country's emphasis on advanced surgical techniques and patient safety outcomes creates strong demand for premium biosurgical products.
  • Healthcare providers are increasingly investing in hemostatic agents, tissue sealants, and regenerative solutions to improve surgical outcomes and reduce complications. The competitive landscape in South Korea is characterized by both established multinational players and emerging local manufacturers.
  • Government initiatives promoting healthcare innovation and reimbursement policies supporting advanced surgical products will further accelerate market expansion.
  • Continued investment in hospital infrastructure and surgeon training programs will sustain demand for biosurgical solutions through the forecast period..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • JOHNSON & JOHNSON

    Key Takeaways

    • South Korea's biosurgery market is valued at USD 272.2 million in 2025 and is expected to reach USD 369.1 million by 2030.
    • South Korea demonstrates a steady CAGR of 6.3%, driven by advanced healthcare infrastructure and high surgical adoption rates.
    • South Korea's aging population and rising chronic disease prevalence are key growth catalysts for biosurgical product demand.
    • South Korea's strong regulatory environment and R&D investment position it as a leading biosurgery market in Asia Pacific.

    Biosurgery Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment BONE MORPHOGENETIC PROTEINS (Type)
    Forecast Period 2025-2030
    Growth Rate CAGR of 6.4% from 2025 to 2030
    Largest Segment HOSPITALS (End User)
    Market Size Base Year (Billions) ~USD 15.83 (2025)
    Revenue Forecast (Billions) ~USD 21.59 (2030)
    Segments Covered Type, Origin, Application, End User, Product

    South Korea Biosurgery Market Report Segmentation

    5 segment dimensions are covered across the global market.

    By Type

    • Albumin-Based Sealants & Adhesives
    • Allografts
    • Biological Meshes
    • Bone Morphogenetic Proteins
    • Collagen & Protein Adhesion Barriers
    • Collagen-Based Sealants & Adhesives
    • Combination Hemostatic Agents
    • Cyanoacrylate-Based Sealants & Adhesives
    • Demineralized Bone Matrix
    • Fibrin-Based Adhesion Barriers
    • Fibrin-Based Sealants & Adhesives
    • Gelatin-Based Sealants & Adhesives
    • Hyaluronic Acid-Based Adhesion Barriers
    • Natural Adhesion Barriers
    • Natural/Biological Sealants & Adhesives
    • Natural/Biological Surgical Sealants & Adhesives
    • Other Bone-Graft Substitutes
    • Other Natural/Biological Surgical Sealants & Adhesives
    • Other Synthetic & Semi-Synthetic Surgical Sealants & Adhesives
    • Other Synthetic Adhesion Barriers
    • Oxidized Regenerated Cellulose-Based Hemostatic Agents
    • Peg Hydrogel-Based Sealants & Adhesives
    • Peg-Based Adhesion Barriers
    • Regenerated Cellulose-Based Adhesion Barriers
    • Synthetic & Semi-Synthetic Surgical Sealants & Adhesives
    • Synthetic Adhesion Barriers
    • Synthetic Bone Grafts
    • Synthetic Meshes
    • Thrombin-Based Hemostatic Agents
    • Urethane-Based Sealants & Adhesives
    • Xenografts

    By Origin

    • Animal-Based Sealants & Adhesives
    • Human Blood-Based Sealants & Adhesives

    By Application

    • Cardiovascular Surgery
    • General Surgery
    • Gynecological Surgery
    • Neurological Surgery
    • Orthopedic Surgery
    • Other Applications
    • Reconstructive Surgery
    • Thoracic Surgery
    • Urological Surgery

    By End User

    • Ambulatory Surgical Centers
    • Clinics
    • Hospitals
    • Other End Users

    By Product

    • Adhesion Barriers
    • Bone-Graft Substitutes
    • Hemostatic Agents
    • Soft-Tissue Attachments
    • Staple-Line Reinforcement Agents
    • Surgical Sealants & Adhesives

    Target Audience

    • Medical Device Manufacturers : Biosurgical product companies seeking to expand or establish operations in South Korea need market sizing, competitive analysis, and regulatory guidance specific to this high-growth market.
    • Healthcare Investors & PE Firms : Investment professionals evaluating opportunities in South Korea's healthcare sector require detailed market forecasts, growth drivers, and competitive positioning data for biosurgery.
    • Hospital & Healthcare Administrators : South Korean hospital procurement teams need market intelligence on biosurgical product availability, pricing trends, and clinical efficacy data to optimize surgical supply decisions.
    • Distributors & Importers : Medical device distributors operating in South Korea require market dynamics, demand forecasts, and competitive landscape data to optimize inventory and sales strategies.
    • Market Research & Consulting Firms : Research organizations and consultants advising clients on South Korea's healthcare market need comprehensive, country-specific biosurgery data for client deliverables and strategic recommendations.

    Reasons to Buy this Report

    • Market-Specific Growth Projections : Obtain precise South Korea market sizing and forecasts (2025-2030) with 6.3% CAGR to inform localized business strategies and investment decisions.
    • Competitive Landscape Intelligence : Understand the competitive dynamics specific to South Korea, including key players, market share distribution, and differentiation strategies in the biosurgery sector.
    • Regulatory & Reimbursement Insights : Gain detailed knowledge of South Korea's regulatory pathways, approval timelines, and reimbursement policies affecting biosurgical product commercialization.
    • Healthcare Infrastructure Analysis : Access data on South Korea's hospital networks, surgical volumes, and adoption rates of minimally invasive techniques to identify market opportunities.
    • Strategic Market Entry Planning : Leverage South Korea-specific market intelligence to develop targeted go-to-market strategies, partnership opportunities, and pricing models for biosurgical products.

    Frequently asked questions

    What is the current size of South Korea's biosurgery market?

    South Korea's biosurgery market is valued at USD 272.2 million in 2025.

    What is the projected market size for South Korea's biosurgery sector by 2030?

    South Korea's biosurgery market is projected to reach USD 369.1 million by 2030.

    What is the CAGR for South Korea's biosurgery market?

    South Korea's biosurgery market is growing at a CAGR of 6.3% from 2025 to 2030.

    What factors are driving growth in South Korea's biosurgery market?

    South Korea's market growth is driven by advanced healthcare infrastructure, an aging population, rising chronic disease prevalence, and strong adoption of minimally invasive surgical techniques.

    How does South Korea's biosurgery market compare to other Asia Pacific countries?

    South Korea is a leading biosurgery market in Asia Pacific, supported by robust regulatory frameworks, significant R&D investment, and favorable reimbursement policies that enhance market competitiveness.

    RESEARCH METHODOLOGY

    The study involved major activities in estimating the current market size for the biosurgery market. Exhaustive secondary research was done to collect information on the biosurgery industry. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the Biosurgery market.

    Secondary Research

    The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, investor presentations, SEC filings of companies and publications from government sources [such as National Institutes of Health (NIH), US FDA, US Census Bureau, World Health Organization (WHO), International Trade Administration (ITA), Global Burden of Disease Study, and Centers for Medicare and Medicaid Services (CMS) were referred to identify and collect information for the global biosurgery market study. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

    Primary Research

    In the primary research process, various supply and demand sources were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations in the biosurgery market. The primary sources from the demand side include ambulatory surgical centers, hospitals, Clinics, and other end users. Primary research was conducted to validate the market segmentation, identify key players, and gather insights on key industry trends & key market dynamics.

    A breakdown of the primary respondents is provided below:

    Biosurgery Market

    *C-level primaries include CEOs, CFOs, COOs, and VPs.

    *Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

    Note: Companies are classified into tiers based on their total revenue. As of 2024, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = < USD 1.00 billion.

    Source: MarketsandMarkets Analysis

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    For the global market value, annual revenues were calculated based on the revenue mapping of major product manufacturers and OEMs active in the global biosurgery market. All the major product manufacturers were identified at the global and/or country/regional level. Revenue mapping for the respective business segments/sub-segments was done for the major players. Also, the global biosurgery market was split into various segments and sub-segments based on:

    • List of major players operating in the products market at the regional and/or country level
    • Product mapping of various biosurgery manufacturers at the regional and/or country level
    • Mapping of annual revenue generated by listed major players from biosurgery (or the nearest reported business unit/product category)
    • Extrapolation of the revenue mapping of the listed major players to derive the global market value of the respective segments/subsegments
    • Summation of the market value of all segments/subsegments to arrive at the global biosurgery market

    The above-mentioned data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.

    Market Size Estimation (Bottom-up Approach and Top-down Approach)

    Biosurgery Market

    Data Triangulation

    After arriving at the global biosurgery market's overall size through the methodology mentioned above, this market was split into several segments and subsegments. Where applicable, the data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact market value data for the key segments and subsegments. The extrapolated market data was triangulated by studying various macro indicators and regional trends from both demand- and supply-side participants.

    Market Definition

    Biosurgery products are essential in surgical procedures, aiding in the repair of damaged tissues and bones. Surgeons utilize these products to stabilize skin, internal organs, and blood vessels, ensuring hemostasis and tissue integrity after injury or surgery. Key types include surgical sealants, hemostatic agents, adhesion barriers, soft-tissue attachments, bone-graft substitutes, and staple-line reinforcement agents, all designed to enhance healing and prevent complications.

    Stakeholders

    • Transfection products manufacturing companies
    • Pharmaceutical & Biopharmaceutical Companies
    • Chemical Companies
    • Biopharmaceutical Companies
    • Contract Research Organizations (CROs)
    • Contract Development and Manufacturing Organizations (CDMOs)
    • Research Institutes and Universities 
    • Venture Capitalists & Investors
    • Government Associations

    Report Objectives

    • To define, describe, segment, and forecast the transfection technologies market by product type, method, application, end user, and region
    • To provide detailed information about the major factors (such as drivers, restraints, opportunities, and challenges) influencing the market growth
    • To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the transfection technologies market in five main regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa, along with their respective key countries
    • To profile the key players in the transfection technologies market and comprehensively analyze their core competencies2 and market shares
    • To track and analyze competitive developments, such as product launches, acquisitions, expansions, collaborations, agreements, and partnerships of the leading players in the transfection technologies market
    • To benchmark players within the transfection technologies market using the ‘Competitive Leadership Mapping’ framework, which analyzes market players based on various parameters, including product portfolio, geographic reach, and market share/rank

    Get the Full Biosurgery Market Report

    Full forecast, segment splits, and company analysis for all Biosurgery Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status